We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP).
- Authors
Kehne, John; Klein, Brian; Raeissi, Shamsi; Sharma, Shalini
- Abstract
For over 40 years, the National Institute of Neurological Disorders and Stroke/National Institutes of Health-funded Anticonvulsant Screening Program has provided a preclinical screening service for participants world-wide that helped identify/characterize new antiseizure compounds, a number of which advanced to the market for the treatment of epilepsy. The newly-renamed Epilepsy Therapy Screening Program (ETSP) has a refocused mission to identify novel agents which will help address the considerable remaining unmet medical needs in epilepsy. These include identifying antiseizure agents for treatment-resistant epilepsy, as well as anti-epileptogenic agents that will prevent the development of epilepsy or disease-modifying agents that will ameliorate or even cure established epilepsy and its comorbidities. This manuscript provides an overview of the ETSP's efforts aimed at identifying the next generation of therapeutic agents to further reduce the suffering from and burden of epilepsy.
- Subjects
EPILEPSY; MELAS syndrome; MULTI-infarct dementia; NEUROLOGICAL disorders; BRAIN diseases
- Publication
Neurochemical Research, 2017, Vol 42, Issue 7, p1894
- ISSN
0364-3190
- Publication type
Article
- DOI
10.1007/s11064-017-2275-z